135 related articles for article (PubMed ID: 15803101)
1. [Glucuronyl paclitaxel (Taxol) derivatives as tumor activated prodrugs].
Bouvier E; Schmidt F; Monneret C
Ann Pharm Fr; 2005 Jan; 63(1):53-62. PubMed ID: 15803101
[TBL] [Abstract][Full Text] [Related]
2. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of beta-glucuronyl carbamate-based prodrugs of paclitaxel as potential candidates for ADEPT.
de Bont DB; Leenders RG; Haisma HJ; van der Meulen-Muileman I; Scheeren HW
Bioorg Med Chem; 1997 Feb; 5(2):405-14. PubMed ID: 9061205
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of taxoids 5. Synthesis and evaluation of novel water-soluble prodrugs of a 3'-desphenyl-3'-cyclopropyl analogue of docetaxel.
Yamaguchi T; Harada N; Ozaki K; Arakawa H; Oda K; Nakanishi N; Tsujihara K; Hashiyama T
Bioorg Med Chem Lett; 1999 Jun; 9(12):1639-44. PubMed ID: 10397492
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and beta-lactamase-mediated activation of a cephalosporin-taxol prodrug.
Rodrigues ML; Carter P; Wirth C; Mullins S; Lee A; Blackburn BK
Chem Biol; 1995 Apr; 2(4):223-7. PubMed ID: 9383424
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs.
Mao Y; Zhang Y; Luo Z; Zhan R; Xu H; Chen W; Huang H
Molecules; 2018 Dec; 23(12):. PubMed ID: 30563132
[TBL] [Abstract][Full Text] [Related]
7. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
8. Cephalosporin prodrugs of paclitaxel for immunologically specific activation by L-49-sFv-beta-lactamase fusion protein.
Vrudhula VM; Kerr DE; Siemers NO; Dubowchik GM; Senter PD
Bioorg Med Chem Lett; 2003 Feb; 13(3):539-42. PubMed ID: 12565967
[TBL] [Abstract][Full Text] [Related]
9. Fluorinated paclitaxel prodrugs for potentiated stability and chemotherapy.
Jiang B; Hao D; Li C; Lu S; Pei Q; Xie Z
J Mater Chem B; 2021 Dec; 9(48):9971-9979. PubMed ID: 34871339
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of simplified taxol analogs based on the T-Taxol bioactive conformation.
Zhao J; Bane S; Snyder JP; Hu H; Mukherjee K; Slebodnick C; Kingston DG
Bioorg Med Chem; 2011 Dec; 19(24):7664-78. PubMed ID: 22071526
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2'-carbamate-linked and 2'-carbonate-linked prodrugs of paclitaxel: selective activation by the tumor-associated protease plasmin.
de Groot FM; van Berkom LW; Scheeren HW
J Med Chem; 2000 Aug; 43(16):3093-102. PubMed ID: 10956217
[TBL] [Abstract][Full Text] [Related]
12. The anti-tumor efficacy of 3-(2-Nitrophenyl) propionic acid-paclitaxel (NPPA-PTX): a novel paclitaxel bioreductive prodrug.
Song P; Yao X; Zhong T; Zhang S; Guo Y; Ren W; Huang D; Duan XC; Yin YF; Zhang SS; Zhang X
Oncotarget; 2016 Jul; 7(30):48467-48480. PubMed ID: 27366947
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery systems: water soluble taxol 2'-poly(ethylene glycol) ester prodrugs-design and in vivo effectiveness.
Greenwald RB; Gilbert CW; Pendri A; Conover CD; Xia J; Martinez A
J Med Chem; 1996 Jan; 39(2):424-31. PubMed ID: 8558510
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel conjugation with the analog of the gonadotropin-releasing hormone as a targeting moiety.
Pribylova M; Dvorakova M; Hanusova V; Nemethova I; Skalova L; Vanek T
Int J Pharm; 2011 Aug; 415(1-2):175-80. PubMed ID: 21669266
[TBL] [Abstract][Full Text] [Related]
15. [Studies on structure modification and structure-activity relationship of new taxoids derived from sinenxan a].
Huang G; Guo J; Liang X
Yao Xue Xue Bao; 1998 Aug; 33(8):576-86. PubMed ID: 12016896
[TBL] [Abstract][Full Text] [Related]
16. Balancing the efficacy vs. the toxicity of promiscuous natural products: Paclitaxel-based acid-labile lipophilic prodrugs as promising chemotherapeutics.
Haider S; Penfornis P; Claudio PP; McChesney JD; Chittiboyina AG
Eur J Med Chem; 2022 Jan; 227():113891. PubMed ID: 34656042
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and bioactivity of simplified paclitaxel analogs based on the T-Taxol bioactive conformation.
Ganesh T; Norris A; Sharma S; Bane S; Alcaraz AA; Snyder JP; Kingston DG
Bioorg Med Chem; 2006 May; 14(10):3447-54. PubMed ID: 16434198
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and bioactivity of a side chain bridged paclitaxel: A test of the T-Taxol conformation.
Hodge M; Chen QH; Bane S; Sharma S; Loew M; Banerjee A; Alcaraz AA; Snyder JP; Kingston DG
Bioorg Med Chem Lett; 2009 May; 19(10):2884-7. PubMed ID: 19359169
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of water-soluble morpholino-decorated paclitaxel prodrugs with remarkably decreased toxicity.
Feng S; Chen K; Wang C; Jiang X; Dong H; Gong Z; Liu K
Bioorg Med Chem Lett; 2016 Aug; 26(15):3598-602. PubMed ID: 27311893
[TBL] [Abstract][Full Text] [Related]
20. Recent progress in structure activity relationship and mechanistic studies of taxol analogues.
Fang WS; Liang XT
Mini Rev Med Chem; 2005 Jan; 5(1):1-12. PubMed ID: 15638787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
